Īrija - angļu - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - diphtheria toxoid tetanus toxoid pertussis toxoid filamentous haemagglutinin (fha) pertactin - suspension for injection

Īrija - angļu - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - diphtheria toxoid tetanus toxoid pertussis toxoid filamentous haemagglutinin (fha) pertactin - suspension for injection - %v/v

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - diphtheria toxoid; tetanus toxoid; pertussis toxoid (pt); haemophilus influenza type b conjugate to; pertactin (69 kda outer membrane protein-69k); inactivated polio virus type 3; inactivated polio virus type 2; inactivated polio virus type 1; filamentous haemagglutinin (fha); r-dna hepatitis b antigen -

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - tetanus toxoid >= 40 iu/dose; bordetella pertussis toxoid (pt) 25 µg/dose; bordetella pertussis filamentous hemagglutinin (fha) 25 µg/dose; bordetella pertussis pertactin 8 µg/dose; diphtheria toxoid (dt) >= 30 iu/dose - suspension for injection in pre-filled syringe - diphteria toxoid, adsorbed; tetanus toxoid adsorbed; bordetella pertussis antigen, adsorbed - pertussis, purified antigen, combinations with toxoids

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - tetanus toxoid >= 40 iu/dose; bordetella pertussis toxoid (pt) 25 µg/dose; bordetella pertussis filamentous hemagglutinin (fha) 25 µg/dose; bordetella pertussis pertactin 8 µg/dose; diphtheria toxoid (dt) >= 30 iu/dose - suspension for injection in pre-filled syringe - diphteria antigen, adsorbed; tetanus toxoid adsorbed; bordetella pertussis - pertussis, purified antigen, combinations with toxoids

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pneumococcal purified capsular polysaccharides; diphtheria crm197 protein -

Kanāda - angļu - Health Canada

pfizer canada ulc - meningococcal polysaccharide vaccine grp c; tetanus toxoid - suspension - 10mcg; 20mcg - meningococcal polysaccharide vaccine grp c 10mcg; tetanus toxoid 20mcg - vaccines

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae; streptococcus pneumoniae -

Kanāda - angļu - Health Canada

pfizer canada ulc - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 3; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6a; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 8; pneumococcal polysaccharide serotype 9v; pneumococcal polysaccharide serotype 10a; pneumococcal polysaccharide serotype 11a; pneumococcal polysaccharide serotype 12f; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 15b; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19a; pneumococcal polysaccharide serotype 19f; pneumococcal polysaccharide serotype 22f; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 33f; corynebacterium diphtheriae crm-197 protein - suspension - 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 4.4mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 2.2mcg; 51mcg - pneumococcal polysaccharide serotype 1 2.2mcg; pneumococcal polysaccharide serotype 3 2.2mcg; pneumococcal polysaccharide serotype 4 2.2mcg; pneumococcal polysaccharide serotype 5 2.2mcg; pneumococcal polysaccharide serotype 6a 2.2mcg; pneumococcal polysaccharide serotype 6b 4.4mcg; pneumococcal polysaccharide serotype 7f 2.2mcg; pneumococcal polysaccharide serotype 8 2.2mcg; pneumococcal polysaccharide serotype 9v 2.2mcg; pneumococcal polysaccharide serotype 10a 2.2mcg; pneumococcal polysaccharide serotype 11a 2.2mcg; pneumococcal polysaccharide serotype 12f 2.2mcg; pneumococcal polysaccharide serotype 14 2.2mcg; pneumococcal polysaccharide serotype 15b 2.2mcg; pneumococcal polysaccharide serotype 18c 2.2mcg; pneumococcal polysaccharide serotype 19a 2.2mcg; pneumococcal polysaccharide serotype 19f 2.2mcg; pneumococcal polysaccharide serotype 22f 2.2mcg; pneumococcal polysaccharide serotype 23f 2.2mcg; pneumococcal polysaccharide serotype 33f 2.2mcg; corynebacterium diphtheriae crm-197 protein 51mcg

Īrija - angļu - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - pertussis toxoid filamentous haemagglutinin (fha) pertactin diphtheria toxoid tetanus toxoid haemophilus influenzae type b polysaccharide tetanus toxoid - powder for suspension for injection